In the fight against what are commonly known as superbugs, the institute engages in basic, translational and clinical research aimed at finding innovative solutions to better diagnose, treat, and prevent antimicrobial-resistant infections.
Grant Program Encourages Research Into Combining Antibiotics to Combat Resistance
The National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health, recently announced a new funding opportunity to support research into how resistance evolves in microbial communities, including how combinations of antibiotics could be used to improve treatment and slow the emergence of resistant infections.
A new video from researchers at Harvard University shows just how quickly bacteria “learn” to defeat antibiotics. In the stunning two-minute time-lapse recording, viewers can see bacteria develop resistance to increasingly higher doses of antibiotics.
Antibiotic resistance is a pressing global public health problem. This first report on trends in antibiotic use in the United States brings together diverse sources of information in both human health care and animal agriculture settings. It complements and informs efforts to set evidence-based goals aimed at reducing unnecessary antibiotic use.
Sign Up
Receive our monthly news and action alerts on antibiotic resistance.
MEDIA CONTACT
Sara Miller
Senior Associate, Communications
202.540.6860
Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.
